Literature DB >> 2842689

A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.

J A Escobedo1, L T Williams.   

Abstract

The receptors for mesenchymal growth factors contain tyrosine kinase coding sequences and exhibit ligand-activated tyrosine kinase activity. A variety of mutations of the epidermal growth factor, insulin and platelet-derived growth factor (PDGF) (manuscript in preparation) receptors that have resulted in a loss of tyrosine kinase activity have produced a concomitant loss of growth factor-stimulated DNA synthesis. Comparison of amino acid sequences of tyrosine kinases shows that these regions in the PDGF receptors in mouse and human contain an insert of unknown function. We have deleted this region, and expressed the altered form of the receptor in fibroblasts which lack PDGF receptors. This had no effect on a number of responses to PDGF, but cells bearing the mutant receptor did not proliferate or synthesize DNA in response to PDGF. This demonstrates that the insert is essential in PDGF-induced mitogenesis, and that PDGF stimulation of the mutant receptor tyrosine kinase and phosphatidylinositol turnover are not sufficient to elicit a mitogenic response to PDGF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842689     DOI: 10.1038/335085a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  53 in total

1.  The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.

Authors:  A Klippel; J A Escobedo; W J Fantl; L T Williams
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex.

Authors:  D K Morrison; D R Kaplan; S G Rhee; L T Williams
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

3.  Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction.

Authors:  J C Yu; M A Heidaran; J H Pierce; J S Gutkind; D Lombardi; M Ruggiero; S A Aaronson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  Identical Mr 70,000 S6 kinase is activated biphasically by epidermal growth factor: a phosphopeptide that characterizes the late phase.

Authors:  M Susa; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 5.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

6.  The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.

Authors:  L B Vogel; D J Fujita
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Isolation and characterization of the alpha platelet-derived growth factor receptor from rat olfactory epithelium.

Authors:  K H Lee; D F Bowen-Pope; R R Reed
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

Review 8.  Platelet-derived growth factor--a growth factor with an expanding role in health and disease.

Authors:  A J Habenicht; P Salbach; U Janssen-Timmen; C Blattner; G Schettler
Journal:  Klin Wochenschr       Date:  1990-01-19

9.  Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways.

Authors:  T Matsui; J H Pierce; T P Fleming; J S Greenberger; W J LaRochelle; M Ruggiero; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus.

Authors:  K A Johnson; J C Stone
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.